Sector portfolio · VC firm · United States

U.S. Venture Partners' Biotech portfolio

U.S. Venture Partners has backed 17 Biotech startups in rounds we track, $1.4B between them, shown by the stage each has reached. The best-funded is Intuity Medical.

17startups backed
4stages
$1.4Braised between them
Series C and laterbiggest stage

U.S. Venture Partners's whole portfolioU.S. Venture Partners's profile

Segment by segment

Series C and later

8 startups · $583M raised

  1. Luma HealthLuma Health is a healthcare technology company founded in 2015 and based in San Mateo, California.United States$152M
  2. Calithera BiosciencesCalithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.United States$115M
  3. Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
  4. NeoChordNeoChord is a medical device company that develops devices that allow mitral valve repair to be performed on a beating heart.United States$63M
  5. SentreHEARTSentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.United States$61M
  6. DeepUlldeepull is a Barcelona-based clinical diagnostics company founded in 2020.Spain$57M
  7. NanoOptoNanoOpto employs nano-optics and nano-manufacturing technologies to develop components for optical systems and networks.United States$24M
  8. Cleave TherapeuticsCleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.United States$12M

Stage not reported

3 startups · $386M raised

  1. Intuity MedicalIntuity Medical develops blood glucose monitoring systems for diabetes management.United States$275M
  2. Ribon TherapeuticsRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.United States$90M
  3. Tolerance BioTolerance Bio is a biotechnology company founded in 2023 and based in Philadelphia, Pennsylvania, with operations in Chapel Hill, United States$20M

Series B

3 startups · $213M raised

  1. Ona TherapeuticsOna Therapeutics is a clinical-stage biotechnology company based in the Barcelona Science Park, Spain.Spain$98M
  2. NeRRe TherapeuticsNeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.United Kingdom$74M
  3. ARTHEx BiotechARTHEx Biotech is a clinical-stage biotechnology company based in Paterna, Valencia, Spain.Spain$41M

Series A

3 startups · $207M raised

  1. Vivet TherapeuticsVivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.France$96M
  2. Minoryx TherapeuticsMinoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.Spain$57M
  3. Curve TherapeuticsCurve Therapeutics is a private biotechnology company based in Southampton, United Kingdom, founded in 2019.United Kingdom$54M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names U.S. Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like U.S. Venture Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.